# Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)

> **NCT02025686** · NA · COMPLETED · sponsor: **Per Rotbøll Nielsen** · enrollment: 16 (actual)

## Conditions studied

- Pain
- Inflammation
- Hyperalgesia

## Interventions

- **DRUG:** Hyperbaric Oxygen
- **OTHER:** Normal ambient conditions

## Key facts

- **NCT ID:** NCT02025686
- **Lead sponsor:** Per Rotbøll Nielsen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-08
- **Final completion:** 2012-10
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2014-01-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02025686

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02025686, "Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02025686. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*